ArticlePloS one2021
Performance evaluation in [18F]Florbetaben brain PET images classification using 3D Convolutional Neural Network.
Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 17 citations in OpenAlex.
- Multimodal MRI accurately identifies amyloid status in unbalanced cohorts in Alzheimer's disease continuum.Network neuroscience (Cambridge, Mass.) · 2025Article
- Deep Learning-Driven Estimation of Centiloid Scales from Amyloid PET Images withBrain sciences · 2024Article
- Article
- The Development and Validation of an AI Diagnostic Model for Sacroiliitis: A Deep-Learning Approach.Diagnostics (Basel, Switzerland) · 2023Article
- Generalizability assessment of COVID-19 3D CT data for deep learning-based disease detection.Computers in biology and medicine · 2022Article
- Application of artificial intelligence in brain molecular imaging.Annals of nuclear medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High accuracy has been reported in deep learning classification for amyloid brain scans, an important factor in Alzheimer's disease diagnosis. However, the possibility of overfitting should be considered, as this model is fitted with sample data. Therefore, we created and evaluated an [18F]Florbetaben amyloid brain positron emission tomography (PET) scan classification model with a Dong-A University Hospital (DAUH) dataset based on a convolutional neural network (CNN), and performed external validation with the Alzheimer's Disease Neuroimaging Initiative dataset. Spatial normalization, count normalization, and skull stripping preprocessing were performed on the DAUH and external datasets. However, smoothing was only performed on the external dataset. Three types of models were used, depending on their structure: Inception3D, ResNet3D, and VGG3D. After training with 80% of the DAUH dataset, an appropriate model was selected, and the rest of the DAUH dataset was used for model evaluation. The generalization potential of the selected model was then validated using the external dataset. The accuracy of the model evaluation for Inception3D, ResNet3D, and VGG3D was 95.4%, 92.0%, and 97.7%, and the accuracy of the external validation was 76.7%, 67.1%, and 85.3%, respectively. Inception3D and ResNet3D were retrained with the external dataset; then, the area under the curve was compared to determine the binary classification performance with a significance level of less than 0.05. When external validation was performed again after fine tuning, the performance improved to 15.3%p for Inception3D and 16.9%p for ResNet3D. In [18F]Florbetaben amyloid brain PET scan classification using CNN, the generalization potential can be seen through external validation. When there is a significant difference between the model classification performance and the external validation, changing the model structure or fine tuning the model can help improve the classification performance, and the optimal model can also be found by collaborating through a web-based open platform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.